SPDR S&P Pharmaceuticals ETF (XPH)
NYSEARCA: XPH · Real-Time Price · USD
46.21
+0.70 (1.54%)
Nov 21, 2024, 12:44 PM EST - Market open
XPH Holdings List
As of Nov 18, 2024
No. | Symbol | Name | % Weight |
---|---|---|---|
1 | CORT | Corcept Therapeutics Incorporated | 4.93% |
2 | LBPH | Longboard Pharmaceuticals, Inc. | 4.26% |
3 | BMY | Bristol-Myers Squibb Company | 4.12% |
4 | VTRS | Viatris Inc. | 3.98% |
5 | ITCI | Intra-Cellular Therapies, Inc. | 3.90% |
6 | JAZZ | Jazz Pharmaceuticals plc | 3.86% |
7 | AXSM | Axsome Therapeutics, Inc. | 3.52% |
8 | CTLT | Catalent, Inc. | 3.52% |
9 | PRGO | Perrigo Company plc | 3.46% |
10 | JNJ | Johnson & Johnson | 3.34% |
11 | RPRX | Royalty Pharma plc | 3.32% |
12 | ELAN | Elanco Animal Health Incorporated | 3.32% |
13 | EWTX | Edgewise Therapeutics, Inc. | 3.32% |
14 | ZTS | Zoetis Inc. | 3.29% |
15 | PFE | Pfizer Inc. | 3.03% |
16 | MRK | Merck & Co., Inc. | 2.97% |
17 | SAVA | Cassava Sciences, Inc. | 2.84% |
18 | LLY | Eli Lilly and Company | 2.81% |
19 | TARS | Tarsus Pharmaceuticals, Inc. | 2.78% |
20 | OGN | Organon & Co. | 2.63% |
21 | PBH | Prestige Consumer Healthcare Inc. | 2.54% |
22 | ARVN | Arvinas, Inc. | 2.43% |
23 | SUPN | Supernus Pharmaceuticals, Inc. | 2.17% |
24 | AMPH | Amphastar Pharmaceuticals, Inc. | 2.05% |
25 | PCRX | Pacira BioSciences, Inc. | 2.01% |
26 | LGND | Ligand Pharmaceuticals Incorporated | 1.77% |
27 | ANIP | ANI Pharmaceuticals, Inc. | 1.50% |
28 | COLL | Collegium Pharmaceutical, Inc. | 1.48% |
29 | OCUL | Ocular Therapeutix, Inc. | 1.30% |
30 | AMRX | Amneal Pharmaceuticals, Inc. | 1.28% |
31 | HRMY | Harmony Biosciences Holdings, Inc. | 1.26% |
32 | HROW | Harrow, Inc. | 1.07% |
33 | MNMD | Mind Medicine (MindMed) Inc. | 1.04% |
34 | WVE | Wave Life Sciences Ltd. | 1.03% |
35 | INVA | Innoviva, Inc. | 1.00% |
36 | LQDA | Liquidia Corporation | 0.90% |
37 | PLRX | Pliant Therapeutics, Inc. | 0.86% |
38 | FULC | Fulcrum Therapeutics, Inc. | 0.80% |
39 | EYPT | EyePoint Pharmaceuticals, Inc. | 0.80% |
40 | NMRA | Neumora Therapeutics, Inc. | 0.70% |
41 | ELVN | Enliven Therapeutics, Inc. | 0.66% |
42 | NUVB | Nuvation Bio Inc. | 0.55% |
43 | EOLS | Evolus, Inc. | 0.55% |
44 | PHAT | Phathom Pharmaceuticals, Inc. | 0.49% |
45 | XERS | Xeris Biopharma Holdings, Inc. | 0.45% |
46 | n/a | Ssi Us Gov Money Market Class State Street Inst Us Gov | 0.11% |
As of Nov 18, 2024